Key Insights

Highlights

Success Rate

92% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

5.0%

1 terminated out of 20 trials

Success Rate

91.7%

+5.2% vs benchmark

Late-Stage Pipeline

30%

6 trials in Phase 3/4

Results Transparency

55%

6 of 11 completed with results

Key Signals

6 with results92% success

Data Visualizations

Phase Distribution

17Total
Not Applicable (6)
P 1 (1)
P 2 (4)
P 3 (1)
P 4 (5)

Trial Status

Completed11
Not Yet Recruiting3
Unknown2
Withdrawn2
Recruiting1
Terminated1

Trial Success Rate

91.7%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (20)

Showing 20 of 20 trials
NCT07379359Not ApplicableNot Yet RecruitingPrimary

The ADHD Kids´ Study for Children 9-12 Years of Age

NCT06215144Phase 2TerminatedPrimary

Study to Evaluate NRCT-101SR in Pediatric Subjects With ADHD

NCT06967857Phase 2RecruitingPrimary

Clinical Trial to Investigate the Safety and Efficacy of Two Dexamfetamine Sulfate Formulations in Adults With ADHD and Moderate to Severe Depression

NCT07300956Phase 4Not Yet RecruitingPrimary

Treating Young Children With Attention Deficit Hyperactivity Disorder

NCT04532190Not ApplicableNot Yet RecruitingPrimary

Finding Alternatives to Standard Treatment for Attention-Deficit Hyperactivity Disorder

NCT06798337Not ApplicableCompletedPrimary

Reward Effects on Cognition, Motor Skills, and Motivation in Children

NCT01107496Phase 1CompletedPrimary

Evaluation of Immediate-Release Viloxazine in Adults With ADHD

NCT04786990Phase 4CompletedPrimary

Open-Label Study of SPN-812 Administered With Psychostimulants in Children and Adolescents With ADHD

NCT05809388Not ApplicableUnknownPrimary

Virtual Reality for Parent Training Intervention

NCT04016779Phase 3CompletedPrimary

Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD

NCT02633527Phase 2CompletedPrimary

Efficacy and Safety of SPN-812 (Viloxazine Extended-release Capsule) in Children With ADHD

NCT02150668Not ApplicableCompletedPrimary

Efficacy of an Organizational Skills Intervention for Middle School Students With ADHD

NCT00475735Phase 2CompletedPrimary

A Study to Test the Safety and Efficacy of MK0249 in Patients With ADHD (0249-018)(COMPLETED)

NCT00631280Not ApplicableCompletedPrimary

Does Active Parent Involvement in Deliberation and Choice Improve Medication Persistence for Their Child With ADHD

NCT00307268CompletedPrimary

Evaluating Clinical Outcomes of Treatment Effectiveness for Children and Adults With ADHD

NCT00931398Phase 4WithdrawnPrimary

Treatment of College Students With Attention-Deficit/Hyperactivity Disorder (ADHD) Using OROS Methylphenidate

NCT00776009Phase 4CompletedPrimary

Efficacy and Safety of Dex-Methylphenidate Extended Release 30 mg Versus 20 mg in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD) in a Laboratory Classroom Setting.

NCT00711724CompletedPrimary

Comparison of Self and Clinician Administered Rating Scales in Patients With ADHD

NCT00323700WithdrawnPrimary

A Naturalistic Prospective Study of Treatment Effectiveness for Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT00252278Phase 4UnknownPrimary

Effect of Atomoxetine on ADHD-Related Insomnia in Children and Adolescents

Showing all 20 trials

Research Network

Activity Timeline